🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Sinovac Biotech clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Sinovac Biotech as lead sponsor. Synced 26 Sep 2026
12Current trials
6Recruiting now
3Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Sinovac Biotech is the lead sponsor of 12 current clinical trials in our China register. 6 are recruiting patients now. The most common phase is Phase 3. The drugs named most often in its trials are Experimental vaccine, DTaP-IPV-Hib and SIPV. The most-studied condition is Epidemic Meningitis.

ClinicalTrials.gov trials by status

  • Recruiting650%
  • Not yet open433%
  • Active, closed217%

Trials by phase

  • Phase 3758%
  • Phase 4325%
  • Phase 118%
  • Phase 1/218%
01

Clinical trials sponsored by Sinovac Biotech

12 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
NCT07400003 · ClinicalTrials.gov ↗ · Herpes Zoster, mRNA Vaccine
Phase 1/2 Recruiting 2026-01 China
Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
NCT07354269 · ClinicalTrials.gov ↗ · Poliomyelitis
Phase 4 Recruiting 2025-09 China
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
NCT07505836 · ClinicalTrials.gov ↗ · Epidemic Meningitis, Meningococcal Vaccines
Phase 3 Recruiting 2026-03 China
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
NCT07505810 · ClinicalTrials.gov ↗ · Epidemic Meningitis, Meningococcal Vaccines
Phase 3 Recruiting 2026-03 China
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months
NCT07505823 · ClinicalTrials.gov ↗ · Epidemic Meningitis, Meningococcal Vaccines
Phase 3 Recruiting 2026-03 China
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
NCT06734832 · ClinicalTrials.gov ↗ · Hand, Foot, and Mouth Disease(HFMD)
Phase 3 Recruiting 2024-12 China
Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine
NCT07418229 · ClinicalTrials.gov ↗ · RSV, mRNA Vaccine
Phase 1 Not yet open 2026-03 China
Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine
NCT07416110 · ClinicalTrials.gov ↗ · Rabies (Healthy Volunteers)
Phase 3 Not yet open 2026-03 China
Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
NCT07611513 · ClinicalTrials.gov ↗ · Hand, Foot, and Mouth Disease(HFMD), Herpangina
Phase 3 Not yet open 2026-05 China
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)
NCT07832201 · ClinicalTrials.gov ↗ · Influenza
Phase 4 Not yet open 2026-10 China
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
NCT06058416 · ClinicalTrials.gov ↗ · Hepatitis A
Phase 4 Active, closed 2023-10 China
Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years
NCT07505888 · ClinicalTrials.gov ↗ · Epidemic Meningitis, Meningococcal Vaccines
Phase 3 Active, closed 2026-03 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Sinovac Biotech trials

3 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Sinovac Biotech trials

12 conditions
Epidemic Meningitis4Meningococcal Vaccines4mRNA Vaccine2RSV1Rabies (Healthy Volunteers)1Hepatitis A1Herpes Zoster1Poliomyelitis1Hand, Foot, and Mouth Disease(HFMD)1Herpangina1Influenza1Hand, Foot, and Mouth Disease(HFMD)1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China126

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Epidemic Meningitis

SponsorTrials
CanSino Biologics2

Sponsors with the most current trials registered for this condition.

06

Questions about Sinovac Biotech trials

How many clinical trials does Sinovac Biotech sponsor?

Sinovac Biotech is the lead sponsor of 12 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Sinovac Biotech trials recruiting?

Yes. 6 of its 12 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Sinovac Biotech testing?

Its current trials name 3 drugs and biologicals as interventions. The most frequent are Experimental vaccine (4), DTaP-IPV-Hib (1) and SIPV (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.